E Fund Management’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-16,746
| Closed | -$74.2K | – | 418 |
|
|
2024
Q4 | $74.2K | Sell |
16,746
-8,739
| -34% | -$38.7K | ﹤0.01% | 385 |
|
|
2024
Q3 | $105K | Buy |
25,485
+2,143
| +9% | +$8.83K | 0.01% | 340 |
|
|
2024
Q2 | $152K | Sell |
23,342
-24,755
| -51% | -$161K | 0.01% | 301 |
|
|
2024
Q1 | $419K | Buy |
48,097
+10,410
| +28% | +$90.7K | 0.03% | 201 |
|
|
2023
Q4 | $431K | Sell |
37,687
-7,209
| -16% | -$82.5K | 0.03% | 186 |
|
|
2023
Q3 | $432K | Buy |
44,896
+5,907
| +15% | +$56.8K | 0.03% | 149 |
|
|
2023
Q2 | $415K | Buy |
38,989
+3,670
| +10% | +$39.1K | 0.03% | 159 |
|
|
2023
Q1 | $372K | Sell |
35,319
-366
| -1% | -$3.86K | 0.03% | 193 |
|
|
2022
Q4 | $442K | Sell |
35,685
-7,619
| -18% | -$94.4K | 0.04% | 159 |
|
|
2022
Q3 | $449K | Buy |
43,304
+6,039
| +16% | +$62.6K | 0.04% | 144 |
|
|
2022
Q2 | $430K | Buy |
37,265
+14,279
| +62% | +$165K | 0.04% | 174 |
|
|
2022
Q1 | $289K | Buy |
22,986
+7,384
| +47% | +$92.8K | 0.01% | 207 |
|
|
2021
Q4 | $182K | Buy |
15,602
+1,472
| +10% | +$17.2K | 0.01% | 271 |
|
|
2021
Q3 | $185K | Buy |
+14,130
| New | +$185K | 0.01% | 236 |
|
|
2021
Q1 | $137K | Buy |
+12,254
| New | +$137K | 0.01% | 226 |
|